Jaquet V - Search Results

1

NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?

Sorce S, Stocker R, Seredenina T, Holmdahl R, Aguzzi A, Chio A, Depaulis A, Heitz F, Olofsson P, Olsson T, Duveau V, Sanoudou D, Skosgater S, Vlahou A, Wasquel D, Krause KH, Jaquet V. Sorce S, et al. Among authors: jaquet v. Free Radic Biol Med. 2017 Nov;112:387-396. doi: 10.1016/j.freeradbiomed.2017.08.006. Epub 2017 Aug 12. Free Radic Biol Med. 2017. PMID: 28811143 Free article. Review.

2

NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation.

Serrander L, Jaquet V, Bedard K, Plastre O, Hartley O, Arnaudeau S, Demaurex N, Schlegel W, Krause KH. Serrander L, et al. Among authors: jaquet v. Biochimie. 2007 Sep;89(9):1159-67. doi: 10.1016/j.biochi.2007.05.004. Epub 2007 May 18. Biochimie. 2007. PMID: 17587483

3

Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Schäppi MG, Jaquet V, Belli DC, Krause KH. Schäppi MG, et al. Among authors: jaquet v. Semin Immunopathol. 2008 Jul;30(3):255-71. doi: 10.1007/s00281-008-0119-2. Epub 2008 May 29. Semin Immunopathol. 2008. PMID: 18509648 Review.

4

NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle.

Basset O, Deffert C, Foti M, Bedard K, Jaquet V, Ogier-Denis E, Krause KH. Basset O, et al. Among authors: jaquet v. Antioxid Redox Signal. 2009 Oct;11(10):2371-84. doi: 10.1089/ars.2009.2584. Antioxid Redox Signal. 2009. PMID: 19309260

5

Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets.

Jaquet V, Scapozza L, Clark RA, Krause KH, Lambeth JD. Jaquet V, et al. Antioxid Redox Signal. 2009 Oct;11(10):2535-52. doi: 10.1089/ars.2009.2585. Antioxid Redox Signal. 2009. PMID: 19309261 Review.

6

Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation.

Bedard K, Attar H, Bonnefont J, Jaquet V, Borel C, Plastre O, Stasia MJ, Antonarakis SE, Krause KH. Bedard K, et al. Among authors: jaquet v. Hum Mutat. 2009 Jul;30(7):1123-33. doi: 10.1002/humu.21029. Hum Mutat. 2009. PMID: 19388116

7

Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, Krause KH. Schiavone S, et al. Among authors: jaquet v. Biol Psychiatry. 2009 Aug 15;66(4):384-92. doi: 10.1016/j.biopsych.2009.04.033. Epub 2009 Jun 26. Biol Psychiatry. 2009. PMID: 19559404

8

The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses.

Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V, Dubois-Dauphin M, Trabace L, Krause KH. Sorce S, et al. Among authors: jaquet v. J Neurosci. 2010 Aug 25;30(34):11317-25. doi: 10.1523/JNEUROSCI.1491-10.2010. J Neurosci. 2010. PMID: 20739552 Free PMC article.

9

NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action.

Jaquet V, Marcoux J, Forest E, Leidal KG, McCormick S, Westermaier Y, Perozzo R, Plastre O, Fioraso-Cartier L, Diebold B, Scapozza L, Nauseef WM, Fieschi F, Krause KH, Bedard K. Jaquet V, et al. Br J Pharmacol. 2011 Sep;164(2b):507-20. doi: 10.1111/j.1476-5381.2011.01439.x. Br J Pharmacol. 2011. PMID: 21501142 Free PMC article.

10

NOX5: from basic biology to signaling and disease.

Bedard K, Jaquet V, Krause KH. Bedard K, et al. Among authors: jaquet v. Free Radic Biol Med. 2012 Feb 15;52(4):725-34. doi: 10.1016/j.freeradbiomed.2011.11.023. Epub 2011 Dec 14. Free Radic Biol Med. 2012. PMID: 22182486 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page